Cell therapy product safety evaluation platform  
Shandong Xinbo is capable of conducting safety evaluations for cell therapy products. Currently, we have conducted pharmacodynamic studies, pharmacokinetic studies, and a full set of preclinical safety evaluations for CGT products such as NK, MSC, and CAR-T.
 ■ Cell counting
 ■ Pharmacodynamic study
 ■ Single-dose toxicity test (rodents)
 ■ Repeated-dose toxicity test (rodents)
 ■ Safety pharmacology test
 ■ Pharmacokinetic test (including method establishment and validation)
 ■ Local toxicity test
 ■ Immunogenicity test (including methodological establishment and validation)
 ■ Tumorigenicity test
 ■ Soft agar cloning assay